Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesSitagliptin treatment of patients with type 2 diabetes does not affect CD4+ T-cell activation
Journal of Diabetes and its Complications, 10/29/09
White PC et al. – The observed increased rate of infection in diabetic patients treated with sitagliptin cannot be explained by a major effect on T–cell activation. Randomized studies, preferably using several assays of immune function, should be performed to confirm and extend these findings.
Related Articles
Sitagliptin 100mg daily effect on DPP-4 inhibition and compound-specific glycemic improvement
Current Medical Research and Opinion, 10/08/09
Relevance Score: 89%
FDA Approves Revisions to Prescribing Information for Diabetes Medications
American Family Physician, 11/06/09
Relevance Score: 87%
Baseline differences in A1C explain apparent differences in efficacy of sitagliptin, rosiglitazone and pioglitazone
Diabetes, Obesity and Metabolism, 10/06/09
Relevance Score: 82%
Today in Diabetes...keeping you current
Receive free subspecialty "5-minute updates" via email
Individuation of different metabolic phenotypes in normal glucose tolerance test
Acta Diabetologia, 11/25/09
Psychometric properties and responsiveness of the Turkish version of the Diabetes Treatment Satisfaction Questionnaire (s) on a sample of diabetics of three consecutive monitoring periods
Acta Diabetologia, 11/25/09
Serum glycated albumin, but not glycated haemoglobin, is low in relation to glycemia in hyperuricemic men
Acta Diabetologia, 11/25/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome
Diabetes Care, 11/25/09
Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight
International Journal of Obesity, 11/25/09
Assessment of Regional Changes in Skeletal Metabolism Following 3 and 18 Months of Teriparatide Treatment
Journal of Bone and Mineral Research, 11/25/09
Sponsor
Article Search
Sponsor